1. Home
  2. ALT vs AII Comparison

ALT vs AII Comparison

Compare ALT & AII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • AII
  • Stock Information
  • Founded
  • ALT 1997
  • AII 2006
  • Country
  • ALT United States
  • AII United States
  • Employees
  • ALT N/A
  • AII N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • AII Property-Casualty Insurers
  • Sector
  • ALT Health Care
  • AII Finance
  • Exchange
  • ALT Nasdaq
  • AII Nasdaq
  • Market Cap
  • ALT 327.4M
  • AII 379.5M
  • IPO Year
  • ALT N/A
  • AII 2025
  • Fundamental
  • Price
  • ALT $3.59
  • AII $20.81
  • Analyst Decision
  • ALT Strong Buy
  • AII Buy
  • Analyst Count
  • ALT 6
  • AII 4
  • Target Price
  • ALT $17.40
  • AII $21.67
  • AVG Volume (30 Days)
  • ALT 2.4M
  • AII 89.1K
  • Earning Date
  • ALT 11-11-2025
  • AII 08-12-2025
  • Dividend Yield
  • ALT N/A
  • AII N/A
  • EPS Growth
  • ALT N/A
  • AII N/A
  • EPS
  • ALT N/A
  • AII 3.87
  • Revenue
  • ALT $20,000.00
  • AII $260,047,000.00
  • Revenue This Year
  • ALT N/A
  • AII $25.82
  • Revenue Next Year
  • ALT $761,880.20
  • AII $25.78
  • P/E Ratio
  • ALT N/A
  • AII $5.20
  • Revenue Growth
  • ALT N/A
  • AII 1.73
  • 52 Week Low
  • ALT $2.90
  • AII $15.78
  • 52 Week High
  • ALT $11.16
  • AII $20.61
  • Technical
  • Relative Strength Index (RSI)
  • ALT 45.32
  • AII N/A
  • Support Level
  • ALT $3.54
  • AII N/A
  • Resistance Level
  • ALT $3.72
  • AII N/A
  • Average True Range (ATR)
  • ALT 0.16
  • AII 0.00
  • MACD
  • ALT 0.02
  • AII 0.00
  • Stochastic Oscillator
  • ALT 21.87
  • AII 0.00

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

About AII American Integrity Insurance Group Inc. Common Stock

American Integrity Insurance Group Inc is engaged in the property and casualty insurance business. It provides personal residential property insurance for single-family homeowners and condominium owners as well as coverage for vacant dwellings and investment properties, predominantly in Florida. The Company's property and casualty insurance is currently offered in Florida, South Carolina, and Georgia.

Share on Social Networks: